Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy

Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy

Abstract Background To scrutinize the pretreatment prognosticators on survival and late toxicities in a homogenous cohort of nasopharyngeal carcinoma (NPC) patients treated by simultaneous integrated boost intensity-modulated radiation therapy (SIB-IMRT). Methods A total of 219 non-distant metastati...

Full description

Bibliographic Details
Main Authors: Yun-Hsuan Lin, Tai-Lin Huang, Chih-Yen Chien, Hui-Chun Chen, Hsuan-Chih Hsu, Eng-Yen Huang, Chong-Jong Wang, Yu-Jie Huang, Yu-Ming Wang, Chun-Chieh Huang, Shang-Yu Chou, Kuan-Cho Liao, Fu-Min Fang
Format: Article
Language:English
Published: BMC 2018-03-01
Series:Radiation Oncology
Subjects:
Nasopharyngeal carcinoma
Simultaneous integrated boost intensity-modulated radiation therapy
Hematologic inflammatory marker
Epstein-Barr virus DNA
Gross tumor volume
Online Access:http://link.springer.com/article/10.1186/s13014-018-0990-5

Internet

http://link.springer.com/article/10.1186/s13014-018-0990-5

Similar Items